Key Highlights
- Bial has a rich history of over 100 years, demonstrating a long-term commitment to patient welfare and therapeutic innovation.
- The company consistently invests more than 20% of its annual revenue in Research and Development (R&D), focusing on neurosciences and rare diseases.
- Bial operates in more than 50 countries, with facilities in key locations such as Spain, Germany, and the United States.
- As a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Bial is recognized for its contributions to the pharmaceutical industry.
- Bial supports various medical and scientific activities through the Bial Foundation, including prestigious awards and research grants.
About Bial
Bial is a family-owned company with over 100 years of history, dedicated to patient welfare and therapeutic innovation. With products available in more than 50 countries, Bial consistently invests over 20% of its annual revenue in Research and Development (R&D), focusing on neurosciences and rare diseases. The company is headquartered in Portugal and has facilities in several countries, including Spain, Germany, and the United States. Bial is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and supports various medical and scientific activities through the Bial Foundation.
Bial's commitment to innovation is evident through its ambitious R&D program and its recognition for supporting medical and scientific research. The company's dedication to patient welfare and therapeutic innovation makes it a significant player in the pharmaceutical industry. Bial's global presence and strong focus on R&D contribute to its reputation as a leader in neurosciences and rare diseases.
For more information, visit www.bial.com. For safety or product quality issues, contact pharmacovigilance@bial.com.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Private Company |
| Parent Company Bial Holding, S.A. |
Subsidiaries & Divisions
Office Locations
- BIAL ANGOLA, LDA
Why Contact Bial?
B2B professionals should contact Bial for potential partnerships in therapeutic innovation and research, as well as for opportunities in the neurosciences and rare diseases sectors.
Who Should Contact Bial for Business?
Sales teams targeting pharmaceutical companies, R&D partners, and recruiters seeking roles in neurosciences and rare diseases should reach out to Bial.
Categories
- Pharmaceutical
- Neurosciences
- Rare Diseases
- Research and Development
- Therapeutic Innovation
- Patient Welfare
- Bial Foundation
- EFPIA
- Global Presence
- Medical Research
More Pharmaceutical Companies
Frequently Asked Questions
- Who is the CEO of Bial?
- While Kees Been is listed as CEO in some databases, the company's leadership is also associated with Bial Holding, S.A. and BIAL - Portela & Cª. S.A.
- What is Kees Been's email at Bial?
- Kees Been's email address is kees.been@bial.com.
- What does Bial do?
- Bial is an innovative pharmaceutical company focused on discovering, developing, and providing new therapeutic solutions, with a strong commitment to Research and Development.
- How many employees does Bial have?
- Bial has approximately 952 employees.
- Where is Bial headquartered?
- Bial is headquartered in Madrid, Spain, at Calle de Alcalá, 265, Edificio 2, Planta 2.
- What industry is Bial in?
- Bial operates in Pharmaceutical, Neurosciences, Rare Diseases.
- When was Bial founded?
- Bial was founded in 1924.
- What is the email format at Bial?
- Bial uses the email format first.last@bial.com.
- Is Bial still active?
- Yes, Bial was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Bial?
- Research Bial's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Bial?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Bial